Cochlear share price jumps on higher dividend and outlook

The Cochlear Limited (ASX: COH) share price is one of the best performers on the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index after it posted its profit results. Here's what you need to know.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price surged higher after the hearing implant company lifted its dividend and forecasted further profit growth in FY20 in its full year profit announcement released this morning.

The Cochlear share price jumped 3.1% to $207.85 in early trade when the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index is struggling at around breakeven.

Other high-profile medical stocks are also trading higher although they are lagging well behind Cochlear at the time of writing. The RESMED/IDR UNRESTR (ASX: RMD) share price increased 0.7% to $19.51 and the CSL Limited (ASX: CSL) share price added 1% to $228.93.

More growth expected in FY20

Cochlear reported a 7% increase in FY19 sales to $1.45 billion and a similar increase in underlying net profit to $265.9 million.

Cochlear is promising stronger growth in FY20 with management tipping a 9% to 13% increase in net profit to between $290 million and $300 million, and has upped its final dividend by 9% to $1.75 a share. This takes the full year distribution to $3.30 per share, or 10% higher than the previous year.

The weakening Australian dollar is helping its cause, but the exciting growth driver was the 20% increase in services revenue as Cochlear implant sales only managed to inch up 2% in the period.

Emerging market issues

Implant sales were impacted by economic strife in emerging markets. Argentina fell into a recession while political tensions triggered a crash in the Turkish lira. There were also 700 fewer Chinese Central Government tender units than last year.

The launch of a competitor product further dented sales in the US and Germany, although Cochlear said sales regained lost ground with the launch of its Nucleus Profile Plus Series cochlear implant in Europe in mid-May and the US in late June.

What's also pleasing is the 15% increase in operating cash flow to $296 million, which prompted the board to lift its dividend by more than profit growth.

"We have a strong balance sheet and generate operating cash flows sufficient to fund investing activities, capital expenditure and acquisitions whilst increasing dividends to shareholders and maintaining conservative gearing levels," said Cochlear's chief executive Dig Howitt.

"We expect strong growth in cochlear implant units in FY20, driven by a number of new products launched late in FY19 and the continued investment in market awareness and access activities."

BrenLau has no position in any of the stocks mentioned. Connect with him on Twitter @brenlau.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another disappointing day for ASX investors this Thursday.

Read more »

two men smiling with a laptop in front of them, symbolising a rising share price.
Share Gainers

Why Pinnacle, PWR, Race Oncology, and Vulcan shares are flying today

These shares are having a good session on Thursday. But why?

Read more »

A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
Share Gainers

Why Boss Energy, Emeco, Mineral Resources, and Plenti shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Share Gainers

3 ASX 300 shares going gangbusters on Wednesday

Investors are bidding up these three ASX 300 shares today. But why?

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a huge Tuesday for ASX shares, with the index resetting its record high.

Read more »